中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共2条，第1-2条 帮助

已选(0)清除 条数/页：   排序方式：
Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying;  Guo, Weijian;  Jia, Tongfu;  Zhao, Qun;  Zhang, Guifang;  He, Yifu;  Zhong, Haijun;  Ba, Yi;  Lin, Xiaoyan;  Yang, Jianwei;  Zhao, Jun;  Bai, Yuxian;  Sun, Guogui;  Wu, Yongjuan;  Wang, Meng;  Sun, Ying
收藏  |  浏览/下载：55/0  |  提交时间：2022/01/10
Arsenic trioxide (ATO) induced degradation of Cyclin D1 sensitized PD-1/PD-L1 checkpoint inhibitor in oral and esophageal squamous cell carcinoma 期刊论文
JOURNAL OF CANCER, 2020, 卷号: 11
作者:  Zhu, Guanxia;  Li, Xia;  Li, Jiong;  Zhou, Wei;  Chen, Zhongjian;  Fan, Yun;  Jiang, Youhua;  Zhao, Yue;  Sun, Guogui;  Mao, Weimin
收藏  |  浏览/下载：83/0  |  提交时间：2020/11/30
esophageal squamous cell carcinoma  oral squamous cell carcinoma  arsenic trioxide  cyclin D1  PD-L1  CDK4/6